GENE ONLINE|News &
Opinion
Blog

NSCLC
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Merck Presents Positive News For Keytruda Combination in NSCLC
2022-09-13
Jounce’s Antibody Misses Primary Endpoint In Phase 2 Lung Cancer Study
2022-08-31
Novartis’s Lung Cancer Drug Approved for Marketing in Europe
2022-06-23
BMS Buys Turning Point Therapeutics For $4.1 Billion, Bringing In Lung Cancer Drug
2022-06-06
BioNTech and Regeneron Expands Cancer Vaccine Collab, Adds Lung Cancer Indication
2022-03-10
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
EQRx, CStone’s Low-Cost anti-PD-L1 Inhibitor Flaunts Encouraging Data in Stage 3 NSCLC
2021-09-19
NHS to Roll Out Revolutionary Lung Cancer Drug Targeting the Once ‘Undruggable’ KRAS
2021-09-12
J&J’s FDA-Approved Bispecific Antibody Registers Promising Phase 1 Results for a Different Indication
2021-08-20
1 2 3 4
LATEST
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
2024-06-18
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
EVENT
Scroll to Top